These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 30534101

  • 1. Validation of the Substance Use Risk Profile Scale (SURPS) With Bulgarian Substance Dependent Individuals.
    Long EC, Milcheva S, Psederska E, Vasilev G, Bozgunov K, Nedelchev D, Gillespie NA, Vassileva J.
    Front Psychol; 2018; 9():2296. PubMed ID: 30534101
    [Abstract] [Full Text] [Related]

  • 2. Validation of the Substance Use Risk Profile Scale in Lithuanian population.
    Kaminskaite M, Pranckeviciene A, Bunevicius A, Janaviciute J, Jokubonis D, Plioplyte A, Lelyte I, Sinkariova L, Jokubka R.
    Health Qual Life Outcomes; 2020 Aug 12; 18(1):276. PubMed ID: 32787865
    [Abstract] [Full Text] [Related]

  • 3. The Substance Use Risk Profile Scale: a scale measuring traits linked to reinforcement-specific substance use profiles.
    Woicik PA, Stewart SH, Pihl RO, Conrod PJ.
    Addict Behav; 2009 Dec 12; 34(12):1042-55. PubMed ID: 19683400
    [Abstract] [Full Text] [Related]

  • 4. Psychometric Evaluation of the Substance Use Risk Profile Scale (SURPS) in an Inpatient Sample of Substance Users Using Cue-Reactivity Methodology.
    Schlauch RC, Crane CA, Houston RJ, Molnar DS, Schlienz NJ, Lang AR.
    J Psychopathol Behav Assess; 2015 Jun 01; 37(1):231-246. PubMed ID: 26052180
    [Abstract] [Full Text] [Related]

  • 5. Adaptation to the Spanish population of the Substance Use Risk Profile Scale (SURPS) and psychometric properties.
    Fernández-Calderón F, Díaz-Batanero C, Rojas-Tejada AJ, Castellanos-Ryan N, Lozano-Rojas ÓM.
    Adicciones; 2018 Jul 12; 30(3):208-218. PubMed ID: 28749526
    [Abstract] [Full Text] [Related]

  • 6. Psychometric evaluation of the Turkish version of the Substance Use Risk Profile Scale in adolescents.
    Uygun SD, Cop E, Uneri OS, Ozdel K, Atar E, Munir KM.
    J Ethn Subst Abuse; 2021 Jul 12; 20(3):379-394. PubMed ID: 31476982
    [Abstract] [Full Text] [Related]

  • 7. Personality and substance use: psychometric evaluation and validation of the Substance Use Risk Profile Scale (SURPS) in English, Irish, French, and German adolescents.
    Jurk S, Kuitunen-Paul S, Kroemer NB, Artiges E, Banaschewski T, Bokde AL, Büchel C, Conrod P, Fauth-Bühler M, Flor H, Frouin V, Gallinat J, Garavan H, Heinz A, Mann KF, Nees F, Paus T, Pausova Z, Poustka L, Rietschel M, Schumann G, Struve M, Smolka MN, IMAGEN consortium.
    Alcohol Clin Exp Res; 2015 Nov 12; 39(11):2234-48. PubMed ID: 26463560
    [Abstract] [Full Text] [Related]

  • 8. [SURPS French version validation in a Quebec adolescent population].
    Castonguay-Jolin L, Perrier-Ménard E, Castellanos-Ryan N, Parent S, Vitaro F, Tremblay RE, Garel P, Séguin JR, Conrod PJ.
    Can J Psychiatry; 2013 Sep 12; 58(9):538-45. PubMed ID: 24099502
    [Abstract] [Full Text] [Related]

  • 9. Validation of the Levenson Self-Report Psychopathy Scale in Bulgarian Substance-Dependent Individuals.
    Psederska E, Yankov GP, Bozgunov K, Popov V, Vasilev G, Vassileva J.
    Front Psychol; 2020 Sep 12; 11():1110. PubMed ID: 32581949
    [Abstract] [Full Text] [Related]

  • 10. Reexamining the Psychometric Properties of the Substance Use Risk Profile Scale.
    Blanchard BE, Stevens AK, Sher KJ, Littlefield AK.
    Assessment; 2020 Apr 12; 27(3):454-471. PubMed ID: 30600689
    [Abstract] [Full Text] [Related]

  • 11. The validity of the Substance Use Risk Profile Scale (SURPS) among Australian adolescents.
    Newton NC, Barrett EL, Castellanos-Ryan N, Kelly E, Champion KE, Stapinski L, Conrod PJ, Slade T, Nair N, Teesson M.
    Addict Behav; 2016 Feb 12; 53():23-30. PubMed ID: 26441044
    [Abstract] [Full Text] [Related]

  • 12. Spanish version of the Substance Use Risk Profile Scale: factor structure, reliability, and validity in Mexican adolescents.
    Robles-García R, Fresán A, Castellanos-Ryan N, Conrod P, Gómez D, de Quevedo Y Domínguez ME, Rafful C, Real T, Vásquez L, Medina-Mora ME.
    Psychiatry Res; 2014 Dec 30; 220(3):1113-7. PubMed ID: 25240942
    [Abstract] [Full Text] [Related]

  • 13. Gender-based measurement invariance of the substance use risk profile scale.
    Memetovic J, Ratner PA, Richardson CG.
    Addict Behav; 2014 Mar 30; 39(3):690-4. PubMed ID: 24296151
    [Abstract] [Full Text] [Related]

  • 14. A model of substance abuse risk: adapting to the Sri Lankan context.
    Chandrika Ismail A, De Alwis Seneviratne R, Newcombe PA, Wanigaratne S.
    Eval Rev; 2009 Feb 30; 33(1):83-97. PubMed ID: 18849482
    [Abstract] [Full Text] [Related]

  • 15. Sensitivity and specificity of a brief personality screening instrument in predicting future substance use, emotional, and behavioral problems: 18-month predictive validity of the Substance Use Risk Profile Scale.
    Castellanos-Ryan N, O'Leary-Barrett M, Sully L, Conrod P.
    Alcohol Clin Exp Res; 2013 Jan 30; 37 Suppl 1():E281-90. PubMed ID: 22974180
    [Abstract] [Full Text] [Related]

  • 16. Neurocognitive and Psychiatric Markers for Addiction: Common vs. Specific Endophenotypes for Heroin and Amphetamine Dependence.
    Long EC, Kaneva R, Vasilev G, Moeller FG, Vassileva J.
    Curr Top Med Chem; 2020 Jan 30; 20(7):585-597. PubMed ID: 32003694
    [Abstract] [Full Text] [Related]

  • 17. Structural, concurrent, and predictive validity of the Substance Use Risk Profile Scale in early adolescence.
    Krank M, Stewart SH, O'Connor R, Woicik PB, Wall AM, Conrod PJ.
    Addict Behav; 2011 Jan 30; 36(1-2):37-46. PubMed ID: 20826056
    [Abstract] [Full Text] [Related]

  • 18. Psychometric properties of the Persian version of the Time to Relapse Questionnaire (TRQ) in substance use disorder.
    Khazaee-Pool M, Moridi M, Ponnet K, Turner N, Pashaei T.
    Am J Drug Alcohol Abuse; 2016 Nov 30; 42(6):682-688. PubMed ID: 27286097
    [Abstract] [Full Text] [Related]

  • 19. Translation, cross-cultural adaptation, and validation of the Bulgarian version of the Liverpool Adverse Event Profile.
    Kuzmanova R, Stefanova I, Velcheva I, Stambolieva K.
    Epilepsy Behav; 2014 Oct 30; 39():88-91. PubMed ID: 25238552
    [Abstract] [Full Text] [Related]

  • 20. Personality dimensions and substance use in individuals with mild to borderline intellectual disabilities.
    Poelen EA, Schijven EP, Otten R, Didden R.
    Res Dev Disabil; 2017 Apr 30; 63():142-150. PubMed ID: 27765413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.